FDA Import Refusal 799-8045242-0/22/1 — Cipla Ltd
The FDA refused shipment 799-8045242-0/22/1 from Cipla Ltd (India) on Jun 20, 2025. The refused product falls under Drugs and Biologics — CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jun 20, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61XCL45 CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC)
- Charges
- 118,75